Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
06/2003
06/25/2003EP1320523A2 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
06/25/2003CN1426396A Substituted benzoic acid amides and use for inhibition of angiogenesis thereof
06/25/2003CN1426395A Inhibitors of dipeptidyl peptidase IV
06/25/2003CN1425655A Method for preparing pyrimidine derivative
06/24/2003US6583286 Method for hydrogenating unsaturated heterocyclic compounds
06/24/2003US6583157 Quinolinyl and benzothiazolyl modulators
06/24/2003US6583144 Piperazine substituted isoquinoline, 1,3-benzoxazine, or 1,3-benzothiazine derivatives; inhibitors against the biosynthesis of triglycerides and secretion of apolipoprotein b and treatment of hyperlipidemia
06/19/2003WO2003049702A2 Vanilloid receptor ligands and their use in treatments
06/19/2003US20030114679 Selective hydrogenation of amino-substituted fused bicyclic aromatic ring system, preparation of racemic amino substituted fused bicyclic ring system via nitrosation, enzymatic resolution of racemic mixture to produce (R)- and (S)-forms
06/19/2003US20030114521 Oxamic acids and derivatives as thyroid receptor ligands
06/19/2003US20030114499 Antiarrhythmic agents for the treatment and prophylaxis of atrial arrhythmias, atrial fibrillation (AF) or atrial flutter; potassium channel modulators, beta-blocker
06/19/2003US20030114490 New phenylalanine derivatives
06/19/2003US20030114480 Anellated dihydropyridines for the treatment of chronic pain
06/19/2003US20030114441 Heterocyclic anti-epileptogenic agents and methods of use thereof
06/19/2003US20030114438 Lactam derivatives as antiarrhythmic agents
06/19/2003US20030114422 Thrombosis, brain disorders, cardiovascular disorders, Alzheimer's disease, Huntington diseases
06/19/2003US20030113665 Optical data medium containing, in the information layer, a dye as a light-absorbing compound
06/19/2003CA2468544A1 Vanilloid receptor ligands
06/18/2003EP1318978A2 N-acylsulfonamide apoptosis promoters
06/18/2003EP1318811A1 Cyclopentyl modulators of chemokine receptor activity
06/17/2003US6579885 For therapy of attention deficit disorder, hyperactivity disorder, anxiety, depression, post-traumatic stress disorder, supranuclear palsy, eating disorders, obsessive compulsive disorder, analgesia, nicotine addiction, Parkinsonism
06/17/2003US6579881 Muscle relaxants, antiserotonine agent
06/12/2003WO2003048129A1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same
06/12/2003WO2003048123A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
06/12/2003WO2003048118A1 5-ht7 receptor antagonists
06/12/2003WO2003047515A2 P2x7 receptor antagonists
06/12/2003WO2002017712A3 Disubstituted benzenes as insecticides
06/12/2003US20030109459 Activity as inhibitors of binding between VCAM-1 and cells expressing VLA-4. Such compounds are useful for treating diseases whose symptoms and/or damage are related to the binding of VCAM-1 to cells expressing VLA-4.
06/12/2003US20030108771 Electroluminescent platinum compounds and devices made with such compounds
06/12/2003CA2469385A1 Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, their use as medicament, and medicament containing them
06/12/2003CA2467435A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
06/11/2003EP1317414A2 Gamma-ketoacid dipeptides as inhibitors of caspase-3
06/11/2003EP1317411A1 Derivatives of naphthalene with comt inhibiting activity
06/11/2003EP0892787B1 Novel alpha-hydroxylic acid derivatives, their production and use
06/11/2003CN1422859A Reaction method of biological alkali, reaction product and use thereof
06/11/2003CN1111156C Alpha, alpha'-diaminoalcohol and preparation process thereof
06/10/2003US6576643 Compounds containing dibenzo(A,D)cycloheptene or dibenz(B,F)oxepine derivatives are useful for treating osteoporosis, cardiovascular diosrders, cancer and inflammation
06/10/2003CA2080406C Improved 7-chloroquinaldine synthesis
06/05/2003WO2003045921A1 Heterocyclic amide compounds as apolipoprotein b inhibitors
06/05/2003WO2002085820A3 Chiral organic compounds and metal coordination complexes thereof
06/05/2003US20030105102 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting PARP activity
06/05/2003US20030105079 Novel phenylalkyl diamine and amide analogs
06/05/2003CA2468716A1 Heterocyclic amide compounds as apolipoprotein b inhibitors
06/04/2003EP1062217B1 Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives
06/03/2003US6573278 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
06/03/2003US6573277 Metalloproteinase inhibitor
06/03/2003US6573264 Heteroaryl alkyl piperazine derivatives
05/2003
05/30/2003WO2003043618A2 Amino diols useful in the treatment of alzheimer's disease
05/30/2003CA2467476A1 Amino diols useful in the treatment of alzheimer's disease
05/29/2003US20030100750 Process for solid supported synthesis of pyruvate-derived compounds
05/29/2003US20030100539 Metabotropic glutamate receptors (mGluR); treating fragile X, autism, mental retardation, schizophrenia and Down's Syndrome
05/29/2003US20030099807 Optical recording medium
05/28/2003EP1314980A2 A system for cell-based screening
05/28/2003EP1313721A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands
05/28/2003EP1313718A2 Inhibitors of copper-containing amine oxidases
05/28/2003EP1155001A4 Isoquinoline derivatives and isoquinoline combinatorial libraries
05/28/2003EP1117627B1 Transfer hydrogenation process
05/28/2003EP1015444B1 Pyrimidine derivatives and processes for the preparation thereof
05/28/2003CN1420872A Caspase inhibitors and use thereof
05/28/2003CN1109672C Process for prodn. of (Z)-1-[1-(4-methoxybenzylidene)-1,2,3,4,5,6,7,8-octahydro-isoquinolin-2-yl] alkanones
05/28/2003CN1109544C Beta-alkoxyacrylates against malaria
05/27/2003US6570027 Method of preparing intermediates useful in synthesis of retroviral protease inhibitors
05/22/2003WO2003042135A2 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
05/22/2003WO2003041721A1 Process for reacting alkaloids and use of the reaction products in the preparation of medicaments
05/22/2003WO2000037429A3 INHIBITORS OF α4β1 MEDIATED CELL ADHESION
05/22/2003US20030096847 For treatment and/or prevention of disorders in the central nervous system, particularly amnesia, dementia, Alzheimer's dementia
05/22/2003US20030096826 Inhibitors of interleukin-1 beta converting enzyme and other cysteine proteases in the ICE family
05/22/2003US20030096192 For application to polycarbonate substrate by spin coating or vapor deposition
05/22/2003US20030096138 An iridium complex of 2-(2-thienyl)-5-trifluoromethyl)pyridine compounds; light-emitting diodes
05/22/2003US20030095958 Inhibiting beta amyloid converting enzyme responsible for A beta peptide cleavage to treat Alzheimer's Disease, Down's Syndrome, etc.
05/22/2003CA2466449A1 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
05/21/2003EP1312602A1 Amidino derivatives, and anticoagulants and thrombosis therapeutic agents containing them
05/21/2003EP1311478A1 Novel thiourea compounds and the pharmaceutical compositions containing the same
05/21/2003EP1311473A2 Novel compounds inhibiting factor xa activity
05/21/2003EP1283711A4 Peptide deformylase inhibitors
05/21/2003EP1023268B1 Isoquinolines as urokinase inhibitors
05/20/2003US6566524 Methods for synthesis of amino-tetrahydroisoquinoline-sulfonamide hydroxamic acids
05/15/2003WO2003040402A2 Alpha-helix mimicry by a class of organic molecules
05/15/2003WO2003040257A1 Electroluminescent platinum compounds and devices made with such compounds
05/15/2003WO2003040256A2 Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds
05/15/2003WO2003040174A2 Substituted amino ketone compounds
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003WO2002004423A9 Thrombin inhibitors comprising an aminoisoquinoline group
05/15/2003WO2001079173A3 Enamine derivatives as cell adhesion molecules
05/15/2003US20030092727 Hydroxamic and carboxylic acid derivatives
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003CA2466143A1 Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds
05/15/2003CA2466119A1 Electroluminescent platinum compounds and devices made with such compounds
05/14/2003EP1208087B1 Diester prodrugs of a decahydroisoquinoline-3-carboxylic acid
05/14/2003CN1418191A Novel thiourea derivatives and the pharmaceutical compositions containing thd same
05/14/2003CN1418187A Carboxylic acid derivatives as IP antagonists
05/14/2003CN1108301C Inhibitors of microsomal triglyceride transfer protein and mothed
05/13/2003US6562977 For use in the synthesis of peptides and/or for the manufacture of pharmaceutically active substances or corresponding intermediates
05/13/2003US6562837 Use of tetrahydroisoquinoline compounds for the treatment of septicemia
05/13/2003US6562822 Heterocyle carboxamides as antiviral agents
05/13/2003US6562819 Compounds for inhibition of ceramide-mediated signal transduction
05/08/2003WO2003037887A1 Therapeutic isoquinoline compounds
05/08/2003WO2003037847A1 Benzamide derivatives as antagonists of orexin receptors
05/08/2003WO2003037308A2 Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion
05/08/2003US20030088103 PPARgamma modulators
1 ... 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 ... 119